Free Radicals in the Brain

[1]  R T Schimke,et al.  Control of enzyme levels in mammalian tissues. , 2006, Advances in enzymology and related areas of molecular biology.

[2]  Abraham Weizman,et al.  alpha-Tocopherol treatment for tardive dyskinesia. , 1992, The Journal of nervous and mental disease.

[3]  R. Wyatt,et al.  DNA repair and mutant frequency in schizophrenia , 1992, Schizophrenia Research.

[4]  R. Ordway,et al.  Direct regulation of ion channels by fatty acids , 1991, Trends in Neurosciences.

[5]  L. Ganzini,et al.  The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study. , 1991, Archives of general psychiatry.

[6]  R. D. Situnayake,et al.  Lipid peroxidation and hepatic antioxidants in alcoholic liver disease. , 1990, Gut.

[7]  R. Sram,et al.  Inhibition of DNA repair synthesis in the rat by in vivo exposure to psychotropic drugs and reversal of the effect by co-administration with alpha-tocopherol. , 1990, Mutation research.

[8]  A. Mori,et al.  Increased aspartic acid release from the iron-induced epileptogenic focus , 1990, Epilepsy Research.

[9]  D. Price,et al.  Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. , 1990, Science.

[10]  B. Jones,et al.  Free Radicals and Tardive Dyskinesia , 1990, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[11]  J. Parks,et al.  Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.

[12]  S. Fahn.  The Endogenous Toxin Hypothesis of the Etiology of Parkinson's Disease and a Pilot Trial of High‐Dosage Antioxidants in an Attempt to Slow the Progression of the Illness , 1989, Annals of the New York Academy of Sciences.

[13]  A. Graybiel,et al.  Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease , 1989, Acta neurologica Scandinavica. Supplementum.

[14]  T. Crow.  A Current View of the Type II Syndrome: Age of Onset, Intellectual Impairment, and the Meaning of Structural Changes in the Brain , 1989, British Journal of Psychiatry.

[15]  Y. Agid,et al.  Striatal dopamine deficiency in parkinson's disease: Role of aging , 1989, Annals of neurology.

[16]  M. Hiramatsu,et al.  Amino acid neurotransmitters in iron-induced epileptic foci of rats. , 1989, Research communications in chemical pathology and pharmacology.

[17]  C. Marsden,et al.  A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra , 1989, Journal of neurochemistry.

[18]  E. Rosen,et al.  The blood-retinal barrier in chloroquine retinopathy. , 1989, Investigative ophthalmology & visual science.

[19]  N. Crosti,et al.  Catalase and glutathione peroxidase activity in cells with trisomy 21 , 1989, Clinical genetics.

[20]  C. Marsden,et al.  Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.

[21]  R. Martins,et al.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. , 1989, The New England journal of medicine.

[22]  K. Vaddadi,et al.  A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia , 1989, Psychiatry Research.

[23]  R. Sram,et al.  The influence of alpha-tocopherol and pyritinol on oxidative DNA damage and lipid peroxidation in human lymphocytes. , 1989, Mutation research.

[24]  C. Marsden,et al.  Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease , 1989, Journal of neurochemistry.

[25]  P. Hwang,et al.  A Randomized, Double‐Blind, Placebo‐Controlled, Clinical Trial of D‐α‐Tocopheryl Acetate (Vitamin E), as Add‐On Therapy, for Epilepsy in Children , 1989, Epilepsia.

[26]  S. De Flora,et al.  Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overview. , 1988, Mutation research.

[27]  J. Cadet,et al.  Partial reversal of the iminodipropionitrile-induced hyperkinetic syndrome in rats by alpha-tocopherol (vitamin E). , 1988, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[28]  J. Penn,et al.  Effects of oxygen rearing on the electroretinogram and GFA-protein in the rat. , 1988, Investigative ophthalmology & visual science.

[29]  J. Birchall,et al.  ALUMINIUM, CHEMICAL PHYSIOLOGY, AND ALZHEIMER'S DISEASE , 1988, The Lancet.

[30]  Haruhiko Akiyama,et al.  Rate of cell death in parkinsonism indicates active neuropathological process , 1988, Annals of neurology.

[31]  B. Ames,et al.  Normal oxidative damage to mitochondrial and nuclear DNA is extensive. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[32]  L. DeLisi,et al.  Cytogenetic studies of males with schizophrenia Screening for the fragile X chromosome and other chromosomal abnormalities , 1988, Schizophrenia Research.

[33]  C. A. Wilson,et al.  Experimental ischemia induces cell mitosis in the adult rat retina. , 1988, Investigative ophthalmology & visual science.

[34]  DNA repair synthesis and lipid peroxidation in schizophrenic patients J. Topinka, B. Binkova and R.J. Sram Psychiatric Research Instituhte, Ustavni 91, CS-181 03 Prague 8, Bohnice, Czechoslovakia , 1988, Schizophrenia Research.

[35]  R D Klausner,et al.  Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. , 1988, Science.

[36]  B. Zeeberg,et al.  Elevated D2 dopamine receptors in drug-naïve schizophrenics. , 1988, Science.

[37]  R D Klausner,et al.  Identification of the iron-responsive element for the translational regulation of human ferritin mRNA. , 1987, Science.

[38]  A. Sevanian,et al.  Role of free radicals in uveitis. , 1987, Survey of ophthalmology.

[39]  J. Lunec,et al.  EVIDENCE OF ENHANCED LIPID PEROXIDATION IN THE CEREBROSPINAL FLUID OF PATIENTS TAKING PHENOTHIAZINES , 1987, The Lancet.

[40]  M. Fukushima.  Guanidino compounds in iron-induced epileptogenic foci of rats , 1987 .

[41]  A. Mori.  Biochemistry and neurotoxicology of guanidino compounds , 1987, The Pavlovian Journal of Biological Science.

[42]  M. Naash,et al.  Effect of light history on retinal antioxidants and light damage susceptibility in the rat. , 1987, Experimental eye research.

[43]  D. Jeste,et al.  ALPHA-TOCOPHEROL IN TARDIVE DYSKINESIA , 1987, The Lancet.

[44]  A. Singer,et al.  DIAGNOSIS OF CERVICAL NEOPLASIA BY THE ESTIMATION OF OCTADECA-9,11-DIENOIC ACID , 1987, The Lancet.

[45]  P. S. St George-Hyslop,et al.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.

[46]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[47]  C. D. Binnie,et al.  Electroencephalographic findings in antiepileptic drug trials: a review and report of 6 studies , 1987, Epilepsy Research.

[48]  W. Triggs,et al.  The role of iron-induced hippocampal peroxidation in acute epileptogenesis , 1986, Brain Research.

[49]  B. Halliwell,et al.  Iron and free radical reactions: two aspects of antioxidant protection , 1986 .

[50]  Voon Wee Yong,et al.  Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients , 1986, Neuroscience Letters.

[51]  J. Gutteridge.  Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides , 1986, FEBS letters.

[52]  M. Levine.  New concepts in the biology and biochemistry of ascorbic acid. , 1986, The New England journal of medicine.

[53]  L. Beauclair,et al.  Tardive Dyskinesia Associated with Metoclopramide , 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[54]  O. Elroy-Stein,et al.  Overproduction of human Cu/Zn‐superoxide dismutase in transfected cells: extenuation of paraquat‐mediated cytotoxicity and enhancement of lipid peroxidation. , 1986, The EMBO journal.

[55]  S. Iannaccone,et al.  Frequency and clinical progression of the vitamin E deficiency neurologic disorder in children with prolonged neonatal cholestasis. , 1985, American journal of diseases of children.

[56]  H. Munro,et al.  Transferrin and its receptor: Their roles in cell function , 1985, Hepatology.

[57]  R. Fink,et al.  INCREASED FREE-RADICAL ACTIVITY IN ALCOHOLICS , 1985, The Lancet.

[58]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[59]  J. McCord,et al.  Oxygen-derived free radicals in postischemic tissue injury. , 1985, The New England journal of medicine.

[60]  D. Calne,et al.  AETIOLOGY OF PARKINSON'S DISEASE , 1983, The Lancet.

[61]  T. Dormandy,et al.  The nature of diene conjugation in human serum, bile and duodenal juice , 1983, FEBS letters.

[62]  Hiroyoshi Khochi.  Brain active oxygen, free radicals, lipid peroxide and the redox state of glutathione in the Fe3+ induced epileptic focus of the rat , 1983 .

[63]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[64]  D. Muller,et al.  VITAMIN E AND NEUROLOGICAL FUNCTION , 1983, The Lancet.

[65]  P. Sinet.  Metabolism of Oxygen Derivatives in Down's Syndrome * , 1982, Annals of the New York Academy of Sciences.

[66]  J. Neese,et al.  Measurement of vitamin A and vitamin E in human serum by high-performance liquid chromatography. , 1982, Journal of chromatography.

[67]  L. Willmore,et al.  Formation of malonaldehyde and focal brain edema induced by subpial injection of FeCl2 into rat isocortex , 1982, Brain Research.

[68]  D. Bouglé,et al.  RETINAL SUPEROXIDE DISMUTASE ACTIVITY IN NEWBORN KITTENS EXPOSED TO NORMOBARIC HYPEROXIA EFFECT OF VITAMIN E , 1982, Pediatric Research.

[69]  C. Frith,et al.  Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. , 1982, Archives of general psychiatry.

[70]  V. Kagan,et al.  [Binding of 3H-serotonin, 3H-diazepam and lipid peroxidation in brain membranes]. , 1981, Biulleten' eksperimental'noi biologii i meditsiny.

[71]  M. Manku,et al.  Possible role of prostaglandin E1 in the affective disorders and in alcoholism. , 1980, British medical journal.

[72]  A. S. Sidorov,et al.  Lipid peroxidation and electric activity of the retina , 1979, Vision Research.

[73]  A. D. Rosen,et al.  Focal epileptogenesis after intracortical hemoglobin injection , 1979, Experimental Neurology.

[74]  S. Snyder,et al.  Neurotransmitter receptors in frontal cortex of schizophrenics. , 1979, Archives of general psychiatry.

[75]  D. Graham.  On the origin and significance of neuromelanin. , 1979, Archives of pathology & laboratory medicine.

[76]  S. Potkin,et al.  Tardive dyskinesia--reversible and persistent. , 1979, Archives of general psychiatry.

[77]  D. Horrobin.  SCHIZOPHRENIA: RECONCILIATION OF THE DOPAMINE, PROSTAGLANDIN, AND OPIOID CONCEPTS AND THE ROLE OF THE PINEAL , 1979, The Lancet.

[78]  J. Bucher,et al.  OXYGEN TOXICITY IN NEONATAL AND ADULT ANIMALS OF VARIOUS SPECIES.: 1180 , 1978 .

[79]  A. Adams,et al.  Plasma tocopherol levels and tocopherol-lipid relationships in a normal population of children as compared to healthy adults. , 1978, The American journal of clinical nutrition.

[80]  J. Munson,et al.  Recurrent seizures induced by cortical iron injection: A model of posttraumatic epilepsy , 1978, Annals of neurology.

[81]  R. C. Garner,et al.  Testing of known carcinogens and noncarcinogens for their ability to induce unscheduled DNA synthesis in HeLa cells. , 1978, Cancer research.

[82]  D. Graham,et al.  Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. , 1978, Molecular pharmacology.

[83]  C. Epstein,et al.  Dosage effects for superoxide dismutase-1 in nucleated cells aneuploid for chromosome 21. , 1977, American journal of human genetics.

[84]  D. Papachristodoulou,et al.  Ultrastructural alterations during the development of retinopathy in sucrose-fed and streptozotocin-diabetic rats. , 1977, Experimental eye research.

[85]  P. Aisen,et al.  Some physicochemical aspects of iron metabolism. , 1976, Ciba Foundation symposium.

[86]  E. Dratz,et al.  Oxidative damage of retinal rod outer segment membranes and the role of vitamin E. , 1976, Biochimica et biophysica acta.

[87]  K. Yagi,et al.  A simple fluorometric assay for lipoperoxide in blood plasma. , 1976, Biochemical medicine.

[88]  J. Lejeune,et al.  Increase in glutathione peroxidase activity in erythrocytes from trisomy 21 subjects. , 1975, Biochemical and biophysical research communications.

[89]  F. Oski,et al.  Role of dietary iron and fat on vitamin E deficiency anemia of infancy. , 1975, The New England journal of medicine.

[90]  K. C. Hayes.  Retinal degeneration in monkeys induced by deficiencies of vitamin E or A. , 1974, Investigative ophthalmology.

[91]  C. Tanford.  Protein-lipid interactions. , 1973, Neurosciences Research Program bulletin.

[92]  M. Horwitt,et al.  RELATIONSHIP BETWEEN TOCOPHEROL AND SERUM LIPID LEVELS FOR DETERMINATION OF NUTRITIONAL ADEQUACY * , 1972, Annals of the New York Academy of Sciences.

[93]  R. Scholz,et al.  Hepatic Microsomal Ethanol Oxidation , 1972 .

[94]  G. Simpson,et al.  A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS , 1970, Acta psychiatrica Scandinavica. Supplementum.

[95]  M. Grossman,et al.  Edema and hemolytic anemia in premature infants. A vitamin E deficiency syndrome. , 1968, The New England journal of medicine.

[96]  Y. Taniguchi,et al.  [Fine structure of retinal blood vessels in human diabetics]. , 1968, Nippon Ganka Gakkai zasshi.

[97]  T. Van Itallie,et al.  Syndrome in premature infants associated with low plasma vitamin E levels and high polyunsaturated fatty acid diet. , 1966, The American journal of clinical nutrition.

[98]  D. Herting.  Perspective on vitamin E. , 1966, The American journal of clinical nutrition.

[99]  D. Firestone.  Progress in the Chemistry of Fats and Other Lipids , 1960 .

[100]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[101]  P. Gyorgy,et al.  Availability of Vitamin E in the Newborn Infant.∗ , 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[102]  C. S. Rose,et al.  Effect of Dietary Factors on Early Mortality and Hemoglobinuria in Rats Following Administration of Alloxan. , 1948, Science.

[103]  E. Fernholz.  On the Constitution of α-Tocopherol , 1938 .

[104]  H. Evans,et al.  THE ISOLATION FROM WHEAT GERM OIL OF AN ALCOHOL, α-TOCOPHEROL, HAVING THE PROPERTIES OF VITAMIN E , 1936 .

[105]  A. M. Pappenheimer,et al.  NUTRITIONAL MUSCULAR DYSTROPHY IN THE GUINEA PIG AND RABBIT , 1931, The Journal of experimental medicine.

[106]  A. M. Pappenheimer,et al.  A CEREBELLAR DISORDER IN CHICKS, APPARENTLY OF NUTRITIONAL ORIGIN , 1931, The Journal of experimental medicine.

[107]  R. Sram,et al.  Side-Effects of Psychotropic Therapy , 1992 .

[108]  A. Stewart.  Gingko biloba extract (EGb 761): Pharmacological activities and clinical applications: F. V. DeFeudis, Elsevier, 1991. FFr250.00 in France, FFr280.00 elsewhere (xii + 187 pages) ISBN 2 906077 24 0 hbk, 2 906077 21 6 pbk , 1992 .

[109]  T. Dormandy.  Free Radical Activity in Chronic Ethanol Intoxication in Humans , 1992 .

[110]  A. Graybiel,et al.  The nigrostriatal system in Parkinson's disease. , 1990, Advances in neurology.

[111]  S. Hodge,et al.  Twin studies and the genetics of Parkinson's disease—a reappraisal , 1990, Movement disorders : official journal of the Movement Disorder Society.

[112]  A. Schapira,et al.  Mitochondrial DNA analysis in Parkinson's disease , 1990, Movement disorders : official journal of the Movement Disorder Society.

[113]  D. Horrobin.  Omega-6 essential fatty acids : pathophysiology and roles in clinical medicine , 1990 .

[114]  P. Riederer,et al.  Iron-Melanin Interaction in Substantia Nigra as the Neurotoxic Component of Parkinson’s Disease , 1990 .

[115]  D. Jeste,et al.  Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms. , 1988, Schizophrenia bulletin.

[116]  P. Riederer,et al.  Biochemical fundamentals of Parkinson's disease. , 1988, The Mount Sinai journal of medicine, New York.

[117]  G. Roberts.  Abnormalities in brain structure in schizophrenia , 1988 .

[118]  P. Hansotia,et al.  Head trauma and epilepsy. , 1988, Wisconsin medical journal.

[119]  R. Berchou,et al.  Post-traumatic epilepsy following head injury. , 1987, Brain injury.

[120]  E. Niki.  Interaction of ascorbate and alpha-tocopherol. , 1987, Annals of the New York Academy of Sciences.

[121]  T. Crow,et al.  The neuropathology of schizophrenia--a progress report. , 1987, British medical bulletin.

[122]  H. Shichi,et al.  Superoxide in ocular inflammation: human and experimental uveitis. , 1986, Journal of free radicals in biology & medicine.

[123]  S. Nagase,et al.  Active oxygen in methylguanidine synthesis. , 1986, Nephron.

[124]  R. Sram,et al.  Effect of ascorbic acid prophylaxis in groups occupationally exposed to mutagens. , 1986, Progress in clinical and biological research.

[125]  L. Fleisher,et al.  Antioxidant activity of aqueous and vitreous humor from the inflamed rabbit eye. , 1986, Current eye research.

[126]  Duvoisin Rc.  Etiology of Parkinson's disease: current concepts. , 1986 .

[127]  C. Nishimura,et al.  Alteration of lipid peroxide and endogenous antioxidant contents in retina of streptozotocin-induced diabetic rats: effect of vitamin A administration. , 1985, Japanese journal of pharmacology.

[128]  A. Barbeau,et al.  Manganese and extrapyramidal disorders (a critical review and tribute to Dr. George C. Cotzias). , 1984, Neurotoxicology.

[129]  G. N. Kryzhanovskiĭ,et al.  [Alpha-tocopherol in the complex treatment of several forms of epilepsy]. , 1984, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova.

[130]  I. Fridovich.  Superoxide radical: an endogenous toxicant. , 1983, Annual review of pharmacology and toxicology.

[131]  C. Marsden.  Neuromelanin and Parkinson's disease. , 1983, Journal of neural transmission. Supplementum.

[132]  S. Ringel,et al.  Progressive neuromuscular disease in children with chronic cholestasis and vitamin E deficiency: diagnosis and treatment with alpha tocopherol. , 1982, The Journal of pediatrics.

[133]  F. Henn,et al.  PHOSPHOLIPIDS AS MARKERS FOR SCHIZOPHRENIA , 1982 .

[134]  R. Hitzemann,et al.  ABNORMALITIES IN MEMBRANE LIPIDS ASSOCIATED WITH DEFICIENCIES IN LITHIUM COUNTERFLOW , 1982 .

[135]  P. Seeman,et al.  BRAIN DOPAMINE RECEPTORS IN SCHIZOPHRENIA , 1982 .

[136]  C. Marsden,et al.  Problems in dyskinesias , 1981 .

[137]  A. Higashi,et al.  Serum vitamin E concentration in patients with severe multiple handicaps treated with anticonvulsants. , 1980, Pediatric pharmacology.

[138]  J. Davis,et al.  Protein content and monoamine oxidase activity in platelets. , 1980, Schizophrenia bulletin.

[139]  J Lejeune,et al.  Trisomy 21 (Down's syndrome). Glutathione peroxidase, hexose monophoshate shunt and I.Q. , 1979, Life sciences.

[140]  K. Vaddadi.  Penicillin and essential fatty acid supplementation in schizophrenia. , 1979, Prostaglandins and medicine.

[141]  大川 博,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction , 1979 .

[142]  C. A. Thomas,et al.  Molecular cloning. , 1977, Advances in pathobiology.

[143]  J. Rankin,et al.  Alcohol and the Liver , 1977, Springer US.

[144]  I. Fridovich.  CHAPTER 6 – Oxygen Radicals, Hydrogen Peroxide, and Oxygen Toxicity , 1976 .

[145]  W. Wolfe,et al.  Oxygen toxicity. , 1975, Annual review of medicine.

[146]  K. Earle.  Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue. , 1968, Journal of neuropathology and experimental neurology.

[147]  H. Evans.  The Pioneer History of Vitamin E , 1962 .

[148]  B. Sure.  DIETARY REQUIREMENTS FOR REPRODUCTION II. THE EXISTENCE OF A SPECIFIC VITAMIN FOR REPRODUCTION , 1924 .